Work

FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)

Year: 2024

Type: article

Study design: Observational Study

Source: Nuklearmedizin - NuclearMedicine

DOI: 10.1055/a-2283-8417

Authors: Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, Reinhard Marks, Kerstin Michalski, Ralph Wäsch, Robert Zeiser, Juri Ruf, Philipp T Meyer, Claudius Klein

Institutions: University of Freiburg, Universitätsklinikum Würzburg, Städtisches Klinikum Karlsruhe

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394593459

FWCI:

Cites: 30

Cited by:

Related to: 10